國家衛生研究院 NHRI:Items for Author

Year

Loading year class tree, please wait....

Items for Author "Hsu, C"

Return to Browse by Author

Showing 92 items.

Collection	Date	Title	Relation
[陳立宗] 期刊論文	2000-07	Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach	-
[陳立宗] 期刊論文	2001-01-01	Comparison of MALT and non-MALT primary large cell lymphoma of the stomach - Does histologic evidence of MALT affect chemotherapy response?	-
[陳立宗] 會議論文/會議摘要	2001-11	Use of thalidomide in the treatment of advanced hepatocellular carcinoma (HCC): With emphasis on using power Doppler sonography to evaluate the vascularity of the tumor and its correlation with tumor response	-
[陳立宗] 期刊論文	2003	Low-dose thalidomide treatment for advanced hepatocellular carcinoma	-
[其他] 期刊論文	2003-10	An investigation of gradient-based reconstruction algorithms for statistical PET transmission imaging	-
[陳立宗] 會議論文/會議摘要	2003-11	Use of power Doppler sonography and circulating angiogenic factors to assess the potential antiangiogenic effect of thalidomide in hepatocellular carcinoma	-
[石曜堂(1999-2006)] 期刊論文	2003-12	Factors contributing to health behaviors among the elderly in Taiwan	-
[其他] 期刊論文	2004-05-04	Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract	-
[其他] 期刊論文	2004-07	Recent advances in non-surgical treatment for advanced hepatocellular carcinoma	-
[陳立宗] 會議論文/會議摘要	2004-07	Comparison of the antitumor activity of thalidomide between hepatitis B (HBV)and hepatitis C (HCV)-related hepatocellular carcinoma (HCC)	-
[常慧如] 會議論文/會議摘要	2004-10	Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of hepatocellular carcinoma	-
[其他] 期刊論文	2004-10-18	Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines	-
[其他] 期刊論文	2005	Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer	-
[陳立宗] 期刊論文	2005-05	Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors	-
[其他] 期刊論文	2005-08	Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis	-
[許志成] 期刊論文	2006	The impact of the tobacco market opening on smoking status in Taiwan: Findings from a secular smoking rates analysis	-
[黃奇英(1998-2005)] 會議論文/會議摘要	2006	The interplay of hNinein and Astrin- hNinein is required for targeting Spindle-associated protein Astrin to the centrosome	-
[陳立宗] 期刊論文	2006-03	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	-
[陳立宗] 期刊論文	2006-05	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	-
[其他] 期刊論文	2006-05	Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis	-
[劉滄梧] 會議論文/會議摘要	2007	A prospective comparative study of prophylactic or therapeutic use of lamivudine for chemotherapy-associated hepatitis B (HBV) reactivation in nowhodgkin's lymphoma (NHL) patients	-
[劉滄梧] 期刊論文	2007-05	Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result	-
[陳立宗] 會議論文/會議摘要	2008	Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment	-
[劉滄梧] 期刊論文	2008-03	A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial	-
[其他] 期刊論文	2008-12	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	-
[陳立宗] 會議論文/會議摘要	2009	Adjuvant interferon therpay after curative therapy for hepatocellular carcinoma (HCC): A meta-analysis	-
[其他] 期刊論文	2009-02	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	-
[其他] 期刊論文	2009-04-24	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	-
[陳立宗] 會議論文/會議摘要	2009-05-20	Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide-the molecular mechanism and the clinical application	-
[劉俊揚] 期刊論文	2009-09-15	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	-
[劉俊揚] 期刊論文	2009-10	Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma	-
[陳立宗] 期刊論文	2010	Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach	-
[劉俊揚] 期刊論文	2010-01-30	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	-
[夏和雄(1996-2012)] 會議論文/會議摘要	2011-02	Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma	-
[陳立宗] 會議論文/會議摘要	2011-02	Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers	-
[劉俊揚] 期刊論文	2011-04	Overexpression of 14-3-3 epsilon predicts tumour metastasis and poor survival in hepatocellular carcinoma	-
[劉俊揚] 期刊論文	2011-12	Increased expression of 14-3-3beta promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma	-
[張書銘] 期刊論文	2012-02	Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma	-
[邱亞文(2005-2013)] 會議論文/會議摘要	2012-09	Dissemination of systematic reviews in hospital setting: A comparative survey for diffusing the Cochrane Library	-
[夏和雄(1996-2012)] 會議論文/會議摘要	2012-09	Early data from a phase I study of nintedanib (BIBF1120) in Asian patients with advanced hepatocellular carcinoma	-
[許志成] 會議論文/會議摘要	2012-11	Expected life-years saved by preventing end-stage renal disease in the elderly with diabetes	-
[劉俊揚] 期刊論文	2013-03	14-3-3epsilon overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma	-
[陳立宗] 會議論文/會議摘要	2013-05	KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial	-
[劉俊揚] 期刊論文	2013-06-20	Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway	-
[陳立宗] 會議論文/會議摘要	2014-01	Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial	-
[劉俊揚] 期刊論文	2014-01-03	Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin	-
[蕭金福] 會議論文/會議摘要	2014-04	Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis	-
[劉滄梧] 期刊論文	2014-06	Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study	-
[陳立宗] 期刊論文	2014-06-20	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity	-
[熊昭] 期刊論文	2014-07	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians	-
[陳立宗] 期刊論文	2014-07	Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer	-
[郭靜娟] 期刊論文	2014-08	Two new acidic diterpenoids from the heartwood of Pinus massoniana LAMB	-
[其他] 期刊論文	2014-12-15	H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis	-
[常慧如] 期刊論文	2015-04	Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide	-
[鄒小蕙] 會議論文/會議摘要	2015-04	Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection	-
[陳立宗] 期刊論文	2015-05	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer	-
[陳立宗] 期刊論文	2015-07	Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review	-
[劉俊揚] 期刊論文	2015-09	Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma	-
[許志成] 會議論文/會議摘要	2015-11	Medical care and costs of patients with systemic lupus erythematosus in Taiwan	-
[許佳賢] 期刊論文	2015-12	Towards an endpoint cell motility assay by a microfluidic platform	-
[劉滄梧] 期刊論文	2015-12	A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer	-
[姜乃榕] 會議論文/會議摘要	2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	-
[陳立宗] 期刊論文	2016-05-03	Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer	-
[鄒小蕙] 會議論文/會議摘要	2017	Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification	-
[姜乃榕] 會議論文/會議摘要	2017-02	A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer	-
[林嬪嬪] 期刊論文	2017-06-01	Interleukin-24 as a target cytokine of environmental aryl hydrocarbon receptor agonist exposure in the lung	-
[鄒小蕙] 期刊論文	2018-08	Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection	-
[許志成] 會議論文/會議摘要	2018-10	Trend and factors associated with preventable hospitalization among chronic obstructive pulmonary disease patients: A decade experience of a national health insurance program	-
[許志成] 會議論文/會議摘要	2018-10	Trend and factors associated with preventable hospitalization among diabetes mellitus patients in a national health insurance program	-
[鄒小蕙] 會議論文/會議摘要	2018-11	TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer	-
[蕭金福] 會議論文/會議摘要	2019-05	An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14)	-
[鄒小蕙] 期刊論文	2020-01	Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection	-
[陳立宗] 期刊論文	2020-01	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study	-
[陳立宗] 期刊論文	2020-03	Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO	-
[蕭金福] 期刊論文	2020-05	An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas	-
[陳立宗] 期刊論文	2020-10	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	-
[溫啟邦(2001-2010)] 會議論文/會議摘要	2021-01	The case for physical activity as an option in the smoking cessation guidelines: Short and long term benefits beyond expectation from regular exercise	-
[黃秀芬] 期刊論文	2021-07	Exploring markers of exhausted CD8 T cells to predict response to immune checkpoint inhibitor therapy for hepatocellular carcinoma	-
[其他] 會議論文/會議摘要	2021-07	A phase I study of biweekly abraxane in combination with oxaliplatin and oral S-1/leucovorin as first line treatment for advanced gastric, pancreatic and biliary tract cancers	-
[其他] 會議論文/會議摘要	2021-07	Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma	-
[劉滄梧] 會議論文/會議摘要	2021-07	Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load	-
[蘇勇曄] 期刊論文	2021-08	Adjuvant versus neoadjuvant immunotherapy for hepatocellular carcinoma: Clinical and immunologic perspectives	-
[其他] 會議論文/會議摘要	2021-10	Pathogenic role of specific macrophage and fibroblast subpopulations in acne keloidalis identified by single cell RNA sequencing	-
[陳立宗] 期刊論文	2022-06-02	Trial Designs for integrating novel therapeutics into the management of intermediate-stage hepatocellular carcinoma	-
[蘇勇曄] 會議論文/會議摘要	2022-07	Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors	-
[陳立宗] 期刊論文	2022-09	Systemic treatment of advanced unresectable hepatocellular carcinoma after first-line therapy: Expert recommendations from Hong Kong, Singapore, and Taiwan	-
[蘇勇曄] 會議論文/會議摘要	2023-06	Aristolochic acid (AA) exposure and telomere maintenance mechanism in liver angiosarcoma (AS)	-
[鄒小蕙] 會議論文/會議摘要	2023-06	Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics	-
[蘇勇曄] 會議論文/會議摘要	2023-11	Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome	-
[陳立宗] 期刊論文	2024-08-06	Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer	-
[陳立宗] 期刊論文	2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	-
[蘇勇曄] 期刊論文	2024-11	Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis	-

Loading...

Category

Year

Items for Author "Hsu, C"